Adhesion Molecule CD44 as a Prognostic Factor in Tongue Cancer

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5197-5202

  Gonzalez Moles, Miguel Angel ^a,d   Bravo, Manuel ^a   Ruiz Avila, Isabel ^b   Esteban, Francisco ^c   Rodriguez Archilla, Alberto ^a   Gonzalez Moles, Salvador ^a   Arias, Bartolome ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Jaen General Hospital   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d Campus de Cartuja   (Spain)

Author keywords

CD44; Oral carcinoma; Survival analysis; Tongue carcinoma

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TONGUE CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TONGUE NEOPLASMS;

EID: 0842300415     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Myers JN, Elkins T, Roberts D and Byers RM: Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122: 44-51, 2000.
2. Krause CJ, Lee JG and McCabe BF: Carcinoma of the oral cavity. Arch Otolaryngol 97: 354-8, 1973.
3. Lee JG and Litton WB: Occult regional metastasis: carcinoma of the oral tongue. Laryngoscope 82: 1273-81, 1972.
4. Hibbert J, Marks NJ, Winter PJ and Shaheen OH: Prognostic factors in oral squamous carcinoma and their relation to clinical staging. Clin Otolaryngol 8: 197-203, 1983.
5. Gonzalez-Moles MA, Esteban F, Rodrvguez-Archilla A, Ruiz-Avila I and Gonzalez-Moles S: Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol 38: 394-7, 2002.
6. Gonzalez-Moles MA, Galindo P and Gutiirrez-Fernindez J et al: P53 protein expression in oral squamous cell carcinoma. Survival analysis. Anticancer Res 21: 2889-94, 2001.
7. Gonzales-Moles MA, Rodrvguez-Archilla A, Ruiz-Avila I, Martvnez AB, Morales-Garcva P and Gonzalez-Moles S: p16 expression in squamous carcinomas of the tongue. Onkologie 25: 433-6, 2002.
8. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P and Lohrs U: Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 35: 484-9, 1999.
9. Bryne M: Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis 4: 70-7, 1998.
10. Mori S, Nose M and Morikawa H et al: A novel evaluation system of metastatic potential of oral squamous cell carcinoma according to the histopathological and histochemical grading. Oral Oncol 34: 549-57, 1998.
11. Borland G, Ross JA and Guy K: Forms and functions of CD44. Immunology 93: 139-48, 1998.
12. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H and Gunthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71-82, 1994.
13. Sneath RJ and Mangham DC: The normal structure and function of CD44 and its role in neoplasia. Mol Pathol 51: 191-200, 1998.
14. Sato S, Miyauchi M and Takekoshi T et al: Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol 36: 545-9, 2000.
15. Spiessl B: International Union Against Cancer. TNM Atlas Illustrated Guide to the TNM, pTNM Classification of Malignant Tumors. 3rd ed. 2nd revision. Berlin, New York: Springer-Verlag, 1992.
16. Arcangeli G, Mauro F, Nervi C and Starace G: A critical appraisal of the usefulness of some biological parameters in predicting tumour radiation response of human head and neck cancer. Br J Cancer Suppl 41: 39S-44S, 1980.
17. Dominech JM and Sarria A: Analisis de Supervivencia. Barcelona: Editorial Graficas Signo, SA, 1993.
18. Dominech JM and Sarria A: Modelo de Regresion de Cox. Barcelona: Editorial Graficas Signo SA, 1993.
19. Hirvikoski P, Tammi R and Kumpulainen E et al: Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch 434: 37-44, 1999.
20. Ioachim E, Assimakopoulos D, Goussia AC, Peschos D, Skevas A and Agnantis NJ: Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA. Histol Histopathol 14: 1113-8, 1999.
21. Kanke M, Fujii M and Kameyama K et al: Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 126: 1217-23, 2000.
22. Fonseca I, Pereira T, Rosa-Santos J and Soares J: Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: A correlation with histological grade, pattern of stromal invasion and cell differentiation. J Surg Oncol 76: 115-20, 2001.
23. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD and Franklin WA: Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122: 627-32, 1996.
24. Helliwell TR: Molecular markers of metastasis in squamous carcinomas. J Pathol 194: 289-93, 2001.
25. Bruno S, Fabbi M and Tiso M et al: Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. Carcinogenesis 21: 893-900, 2000.
26. Sato S, Miyauchi M and Ogawa I et al: Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells. Oral Oncol 39: 27-30, 2003.